novel protein, GGPS1-TBCE readthrough

The "novel protein, GGPS1-TBCE readthrough" refers to a hypothetical protein produced by a readthrough transcription event at the GGPS1 and TBCE gene locus on chromosome 1. This readthrough fusion is annotated in human genome databases but has not been experimentally validated as a stable protein product, nor has it been ascribed any molecular function, biological activity, or relevance as a therapeutic target. Both parent genes, GGPS1 (geranylgeranyl diphosphate synthase 1) and TBCE (tubulin-specific chaperone E), have well-established independent roles, but the proposed readthrough product "GGPS1-TBCE" lacks evidence for expression, conservation, function, or involvement in disease or pharmacology. There are no known drugs, biomarkers, or safety issues associated with this locus. This annotation likely represents either a rare or non-functional transcript and is not considered a genuine therapeutic target.